| Waddy Osvaldo Gonzalez Diaz, MD | |
|
2385 E Prater Way Ste 302, Sparks, NV 89434-9638 | |
| (775) 356-4514 | |
| (775) 356-4991 |
| Full Name | Waddy Osvaldo Gonzalez Diaz |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 18 Years |
| Location | 2385 E Prater Way Ste 302, Sparks, Nevada |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851636294 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 19199 (Nevada) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northern Nevada Medical Center | Sparks, NV | Hospital |
| Renown Regional Medical Center | Reno, NV | Hospital |
| Banner Churchill Community Hospital | Fallon, NV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northern Nevada Medical Group, Llc | 7214093020 | 71 |
News Archive
On New Year's Eve of 2012, the US Food and Drug Administration (FDA) announced its approval of crofelemer (Fulyzaq, Salix Pharmaceuticals, Ltd., Raleigh, North Carolina) — marking the second time a botanical, and the first time an orally administered botanical, has received drug approval from the Administration.
Twenty percent of American deaths each year are caused by heart attack or angina, sometimes without any warning.
Biomedical engineers at Duke University have devised a test to quickly and easily assess how well a person's neutralizing antibodies fight infection from multiple variants of COVID-19 such as Delta and the newly discovered Omicron variant.
Patients with the heart rhythm disorder atrial fibrillation (AFib) who received first-line catheter ablation treatment had a longer arrhythmia-free interval than patients receiving antiarrhythmic drugs, the standard first-line treatment.
› Verified 1 days ago
| Entity Name | Northern Nevada Medical Group, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972751618 PECOS PAC ID: 7214093020 Enrollment ID: O20090303000483 |
News Archive
On New Year's Eve of 2012, the US Food and Drug Administration (FDA) announced its approval of crofelemer (Fulyzaq, Salix Pharmaceuticals, Ltd., Raleigh, North Carolina) — marking the second time a botanical, and the first time an orally administered botanical, has received drug approval from the Administration.
Twenty percent of American deaths each year are caused by heart attack or angina, sometimes without any warning.
Biomedical engineers at Duke University have devised a test to quickly and easily assess how well a person's neutralizing antibodies fight infection from multiple variants of COVID-19 such as Delta and the newly discovered Omicron variant.
Patients with the heart rhythm disorder atrial fibrillation (AFib) who received first-line catheter ablation treatment had a longer arrhythmia-free interval than patients receiving antiarrhythmic drugs, the standard first-line treatment.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Waddy Osvaldo Gonzalez Diaz, MD 2345 E Prater Way Ste 207, Sparks, NV 89434-9634 Ph: (775) 356-4514 | Waddy Osvaldo Gonzalez Diaz, MD 2385 E Prater Way Ste 302, Sparks, NV 89434-9638 Ph: (775) 356-4514 |
News Archive
On New Year's Eve of 2012, the US Food and Drug Administration (FDA) announced its approval of crofelemer (Fulyzaq, Salix Pharmaceuticals, Ltd., Raleigh, North Carolina) — marking the second time a botanical, and the first time an orally administered botanical, has received drug approval from the Administration.
Twenty percent of American deaths each year are caused by heart attack or angina, sometimes without any warning.
Biomedical engineers at Duke University have devised a test to quickly and easily assess how well a person's neutralizing antibodies fight infection from multiple variants of COVID-19 such as Delta and the newly discovered Omicron variant.
Patients with the heart rhythm disorder atrial fibrillation (AFib) who received first-line catheter ablation treatment had a longer arrhythmia-free interval than patients receiving antiarrhythmic drugs, the standard first-line treatment.
› Verified 1 days ago
Joseph Jay Teichgraeber, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 5975 S Los Altos Pkwy, Suite 100, Sparks, NV 89436 Phone: 775-352-3080 Fax: 775-327-4121 | |
Thomas Nicholas Truong, D.O Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2385 E Prater Way, Suite 302, Sparks, NV 89434 Phone: 775-356-4514 Fax: 775-356-4991 | |
Lynda L Molloy, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2375 E. Prater Way, Sparks, NV 89434 Phone: 775-352-5301 Fax: 775-352-5303 | |
Vijaya Veena Bayya, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 2345 E Prater Way, Suite 104, Sparks, NV 89434 Phone: 775-352-5300 Fax: 775-356-5590 | |
Dr. Ayodele Okunola, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2375 E Prater Way, Sparks, NV 89434 Phone: 775-352-5301 Fax: 775-352-5303 | |
Dr. Kosta M. Arger, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2385 E Prater Way Ste 302, Sparks, NV 89434 Phone: 775-356-4514 Fax: 775-356-4991 | |
Tim Nguyen, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1525 Los Altos Pkwy, Sparks, NV 89436 Phone: 775-982-5000 Fax: 775-982-3900 |